Infinitopes Expands Seed Financing to $35 Million to Accelerate Clinical Development of Precision Cancer Vaccine
PR Newswire —
Financing co-led by Octopus Ventures and new investor Amplify Bio Company readies its first-in-human clinical trial of ITOP1, a precision cancer vaccine designed to prevent recurrence in oesophageal cancer OXFORD, England, Jan. 21, 2026 /PRNewswire/ -- Infinitopes, a clinical-stage cancer...